Janssen (Johnson & Johnson)
COVID-19 Vaccine Update
Wednesday, April 28 at 3:00 PM ET
As of April 21, 2021, 213 million doses of the COVID-19 vaccine have been administered in the United States using the Pfizer-BioNTech, Moderna, and Johnson & Johnson/Janssen vaccines. Dr. Nina Ahmad, US Medical Affairs Director for Janssen’s COVID-19 Vaccine, will provide a vaccine update.
Speaker & Moderators
Speaker: Nina Ahmad, MD
US Medical Affairs Director – COVID-19 Vaccine, Janssen Infectious Diseases
Moderator: Paul Wax, MD, FACMT
Executive Director, American College of Medical Toxicology (ACMT)
Moderator: Ziad Kazzi, FACMT
Secretary Treasurer, ACMT; Past President, Middle East & North Africa Clinical Toxicology Association
Webinar Series Partners:
American Academy of Clinical Toxicology (AACT) | American Academy of Emergency Medicine (AAEM) | American Academy of Emergency Nurse Practitioners (AAENP) | American Association of Poison Control Centers (AAPCC) | American College of Medical Toxicology (ACMT) | Asia Pacific Association of Medical Toxicologists (APAMT) | Association of Healthcare Emergency Preparedness Professionals (AHEPP) | Emergency Nurses Association (ENA) | European Association of Poison Centers and Clinical Toxicologists (EAPCCT) | Middle East & North Africa Clinical Toxicology Association (MENATOX)
ACMT 2020 Digital Annual Report
Learn more about ACMT’s COVID-19 Response, education programs, grants and collaborative projects, Toxicology Investigators Consortium (ToxIC), the Journal of Medical Toxicology, the Medical Toxicology Foundation, and more!